MedPath

A prospective study of salvage radiotherapy combined with horrmone therapy for high-risk recurrent prostate cancer after radical prostatectomy

Not Applicable
Recruiting
Conditions
Recurrent prostate cancer after radical prostatectomy
Registration Number
JPRN-UMIN000030864
Lead Sponsor
Department of Urology, Nara Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Inappropriate for the enrolment by the judgement of the physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Second biochemical recurrence-free survival
Secondary Outcome Measures
NameTimeMethod
1) Salvage hormone therapy-free survival 2) Metastatic-free survival 3) Cancer-specific survival 4) Overall survival 5) Adverse event 6) Body composition analysis after treatment 7) Health-related quality of life after treatment
© Copyright 2025. All Rights Reserved by MedPath